Ticagrelor and absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization.

Trial Profile

Ticagrelor and absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2015

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Arterial occlusive disorders; Coronary disorders
  • Focus Therapeutic Use
  • Acronyms TIGER-BVS
  • Most Recent Events

    • 31 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 01 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top